PL365463A1 - Treatment of osteoarthritis - Google Patents

Treatment of osteoarthritis

Info

Publication number
PL365463A1
PL365463A1 PL00365463A PL36546300A PL365463A1 PL 365463 A1 PL365463 A1 PL 365463A1 PL 00365463 A PL00365463 A PL 00365463A PL 36546300 A PL36546300 A PL 36546300A PL 365463 A1 PL365463 A1 PL 365463A1
Authority
PL
Poland
Prior art keywords
osteoarthritis
treatment
Prior art date
Application number
PL00365463A
Other languages
Polish (pl)
Inventor
Carl M. Mendel
Timothy B. Seaton
Steven P. Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of PL365463A1 publication Critical patent/PL365463A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL00365463A 1999-03-19 2000-03-17 Treatment of osteoarthritis PL365463A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12530099P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
PL365463A1 true PL365463A1 (en) 2005-01-10

Family

ID=22419072

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00365463A PL365463A1 (en) 1999-03-19 2000-03-17 Treatment of osteoarthritis

Country Status (20)

Country Link
EP (1) EP1169027A4 (en)
JP (2) JP2002539248A (en)
KR (1) KR20020038567A (en)
CN (1) CN1352552A (en)
AU (1) AU773490B2 (en)
BG (1) BG105999A (en)
BR (1) BR0009081A (en)
CA (1) CA2366660A1 (en)
CZ (1) CZ20013284A3 (en)
HK (1) HK1044702A1 (en)
HU (1) HUP0200494A2 (en)
IL (1) IL145238A0 (en)
MX (1) MXPA01009461A (en)
NO (1) NO20014477L (en)
NZ (1) NZ514016A (en)
PL (1) PL365463A1 (en)
SK (1) SK13342001A3 (en)
TR (1) TR200102699T2 (en)
WO (1) WO2000056306A1 (en)
ZA (1) ZA200107682B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
ZA836848B (en) * 1982-09-30 1984-05-30 Boots Co Plc Therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
AU4542893A (en) * 1992-06-23 1994-01-24 Sepracor, Inc. Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
WO1994000047A1 (en) * 1992-06-23 1994-01-06 Sepracor Inc. Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
JP3862295B2 (en) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 Anti-obesity agent
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
WO1995032945A1 (en) * 1994-06-01 1995-12-07 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell mediated conditions
GB9619962D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
MA24500A1 (en) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd CARBOXYLIC ACID SALT DERIVATIVE FROM NAPHTHYRIDINE.

Also Published As

Publication number Publication date
NO20014477L (en) 2001-11-01
SK13342001A3 (en) 2002-04-04
EP1169027A4 (en) 2004-10-20
IL145238A0 (en) 2002-06-30
MXPA01009461A (en) 2004-03-19
TR200102699T2 (en) 2002-03-21
ZA200107682B (en) 2003-06-18
BR0009081A (en) 2003-03-05
CA2366660A1 (en) 2000-09-28
EP1169027A1 (en) 2002-01-09
CN1352552A (en) 2002-06-05
NZ514016A (en) 2001-09-28
WO2000056306A1 (en) 2000-09-28
AU3893200A (en) 2000-10-09
AU773490B2 (en) 2004-05-27
CZ20013284A3 (en) 2002-10-16
NO20014477D0 (en) 2001-09-14
HK1044702A1 (en) 2002-11-01
BG105999A (en) 2002-06-28
JP2002539248A (en) 2002-11-19
HUP0200494A2 (en) 2002-08-28
JP2012051904A (en) 2012-03-15
KR20020038567A (en) 2002-05-23

Similar Documents

Publication Publication Date Title
HK1161893A1 (en) Treatment of coal
GB2351661B (en) Novel method of treatment
IL145875A0 (en) Novel method of treatment
GB9925136D0 (en) Novel treatment
PL349347A1 (en) Novel treatment
AU3896900A (en) Treatment of pain
NZ513686A (en) Treatment of trauma
GB9924087D0 (en) Treatment of process fluids
IL145238A0 (en) Treatment of osteoarthritis
IL149281A0 (en) Treatment of cancer
GB9930688D0 (en) Novel method of treatment
GB0205263D0 (en) Treatment of chemical hydrolysates
HUP0203741A3 (en) Treatment of osteoporosis
PL351081A1 (en) Treatment of hiatial hernia
GB9911183D0 (en) Treatment of cancers
GB9930696D0 (en) Novel method of treatment
GB9917181D0 (en) Methods of treatment
GB9901310D0 (en) Methods of treatment
EP1165060A4 (en) Treatment of gallstones
GB9927005D0 (en) Treatment of cancers
GB9918534D0 (en) Treatment of cancers
GB9911346D0 (en) Treatment of cancers
GB9930689D0 (en) Novel method of treatment
GB9930692D0 (en) Novel method of treatment
GB9930690D0 (en) Novel method of treatment